Select a chapter: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 18 21
| Chapter 10 : Musculoskeletal and joint diseases | |
| Section | Name |
| 10.01.03 | Abatacept Orencia® |
| 10.01.03 | Adalimumab |
| 10.01.04 | Allopurinol First Choice |
| 10.01.03 | Anakinra Kineret® |
| 10.01.03 | Apremilast Otezla® |
| 10.02 | Ataluren Translarna ® |
| 10.01.03 | Azathioprine |
| 10.02.02 | Baclofen |
| 10.01.03 | Baricitinib |
| 10.01.03 | Belimumab Benlysta® |
| 10.01.03 | Bimekizumab Bimzelx® |
| 10.02.02 | Cannabis extract Sativex® |
| 10.03.02 | Capsaicin Qutenza® |
| 10.03.02 | Capsaicin |
| 10.01.01 | Celecoxib |
| 10.01.03 | Certolizumab Pegol Cimzia® |
| 10.01.03 | Ciclosporin |
| 10.01.04 | Colchicine |
| 10.01.03 | Cyclophosphamide |
| 10.02.02 | Dantrolene |
| 10.02.02 | Diazepam |
| 10.04 | Dibotermin alfa InductOs® |
| 10.01.01 | Diclofenac |
| 10.01.01 | Diclofenac |
| 10.01.03 | Etanercept |
| 10.01.01 | Etoricoxib |
| 10.01.04 | Febuxostat Second Choice |
| 10.01.03 | Filgotinib Jyseleca® |
| 10.01.03 | Golimumab Simponi® |
| 10.01.03 | Guselkumab Tremfya® |
| 10.03.01 | Hyaluronidase |
| 10.01.03 | Hydroxychloroquine |
| 10.01.01 | Ibuprofen First Choice |
| 10.03.02 | Ibuprofen gel |
| 10.01.01 | Indometacin |
| 10.01.03 | Infliximab |
| 10.01.03 | Ixekizumab Taltz® |
| 10.01.03 | Leflunomide |
| 10.01.01 | Mefenamic acid |
| 10.01.01 | Meloxicam |
| 10.01.03 | Methotrexate |
| 10.01.02.02 | Methylprednisolone Acetate Depo-Medrone® |
| 10.01.02.02 | Methylprednisolone Acetate with Lidocaine Depo-Medrone® with lidocaine |
| 10.02.02 | Mexiletine hydrochloride Namuscla ® |
| 10.01.03 | Mycophenolate Mofetil |
| 10.01.01 | Naproxen First Choice |
| 10.02 | Nusinersen Spinraza® |
| 10.02 | Onasemnogene abeparvovec Zolgensma® |
| 10.01.03 | Penicillamine |
| 10.01.01 | Phenylbutazone |
| 10.02.01 | Pyridostigmine Bromide |
| 10.02.02 | Quinine |
| 10.01.04 | Rasburicase Fasturtec® |
| 10.01.03 | Risankizumab Skyrizi® |
| 10.02 | Risdiplam Evrysdi® |
| 10.01.03 | Rituximab Biosimilars avaliable |
| 10.03.02 | Rubefacients |
| 10.01.03 | Sarilumab Kevzara® |
| 10.01.03 | Secukinumab Cosentyx® |
| 10.01.03 | Sulfasalazine |
| 10.05 | Therabite Jaw Rehabilitation Device Therabite ® |
| 10.02.02 | Tizanidine |
| 10.01.03 | Tocilizumab Biosimilars avaliable |
| 10.01.03 | Tofacitinib Xeljanz® |
| 10.01.03 | Upadacitinib Rinvoq ® |
| 10.01.03 | Ustekinumab |
| 10.02 | Vamorolone Agamree® |